Feagan BG - Search Results

1

Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.

Solitano V, Vuyyuru SK, MacDonald JK, Zayadi A, Parker CE, Narula N, Peyrin-Biroulet L, Danese S, Feagan BG, Singh S, Ma C, Jairath V. Solitano V, et al. Among authors: feagan bg. J Crohns Colitis. 2023 Nov 24;17(11):1800-1816. doi: 10.1093/ecco-jcc/jjad100. J Crohns Colitis. 2023. PMID: 37317532

2

A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty.

Wong CJ, Vandervoort MK, Vandervoort SL, Donner A, Zou G, MacDonald JK, Freedman J, Karkouti K, MacDonald SJ, Feagan BG. Wong CJ, et al. Among authors: feagan bg. Transfusion. 2007 May;47(5):832-41. doi: 10.1111/j.1537-2995.2007.01197.x. Transfusion. 2007. PMID: 17465948 Clinical Trial.

3

Introduction to Cochrane systematic reviews.

Feagan BG, McDonald JW, Chande N, MacDonald JK. Feagan BG, et al. Inflamm Bowel Dis. 2011 Jan;17(1):334-5. doi: 10.1002/ibd.21372. Inflamm Bowel Dis. 2011. PMID: 20848548 No abstract available.

4

Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: a systematic review and meta-analysis.

Feagan BG, MacDonald JK. Feagan BG, et al. Inflamm Bowel Dis. 2012 Sep;18(9):1785-94. doi: 10.1002/ibd.23024. Epub 2012 May 29. Inflamm Bowel Dis. 2012. PMID: 22644954 Review.

5

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Feagan BG, Macdonald JK. Feagan BG, et al. Cochrane Database Syst Rev. 2012 Oct 17;10:CD000543. doi: 10.1002/14651858.CD000543.pub3. Cochrane Database Syst Rev. 2012. PMID: 23076889 Updated. Review.

6

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

Feagan BG, Macdonald JK. Feagan BG, et al. Cochrane Database Syst Rev. 2012 Oct 17;10:CD000544. doi: 10.1002/14651858.CD000544.pub3. Cochrane Database Syst Rev. 2012. PMID: 23076890 Updated. Review.

7

Methotrexate for induction of remission in refractory Crohn's disease.

McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG. McDonald JW, et al. Among authors: feagan bg. Cochrane Database Syst Rev. 2012 Dec 12;12:CD003459. doi: 10.1002/14651858.CD003459.pub3. Cochrane Database Syst Rev. 2012. PMID: 23235598 Updated. Review.

8

Are there any differences in the efficacy and safety of different formulations of Oral 5-ASA used for induction and maintenance of remission in ulcerative colitis? evidence from cochrane reviews.

Feagan BG, Chande N, MacDonald JK. Feagan BG, et al. Inflamm Bowel Dis. 2013 Aug;19(9):2031-40. doi: 10.1097/MIB.0b013e3182920108. Inflamm Bowel Dis. 2013. PMID: 23811638 Review.

9

Vedolizumab as induction and maintenance therapy for ulcerative colitis.

Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A; GEMINI 1 Study Group. Feagan BG, et al. N Engl J Med. 2013 Aug 22;369(8):699-710. doi: 10.1056/NEJMoa1215734. N Engl J Med. 2013. PMID: 23964932 Free article. Clinical Trial.

10

Treat to target: a proposed new paradigm for the management of Crohn's disease.

Bouguen G, Levesque BG, Feagan BG, Kavanaugh A, Peyrin-Biroulet L, Colombel JF, Hanauer SB, Sandborn WJ. Bouguen G, et al. Among authors: feagan bg. Clin Gastroenterol Hepatol. 2015 Jun;13(6):1042-50.e2. doi: 10.1016/j.cgh.2013.09.006. Epub 2013 Sep 10. Clin Gastroenterol Hepatol. 2015. PMID: 24036054 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

493 results

Search Page